Prevalence of CCR5Δ32 polymorphism in long-term survivors of heart transplantation

Transplant Immunology

Volumn 17, Issue 3, 2007, Pages 223-226

  Hummel, Manfred ^a   Bara, Christoph ^b   Hirt, Stephan ^c   Haverich, Axel ^b   Hetzer, Roland ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

CCR5; Heart transplantation; Homozygous; Polymorphism; Survival

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ALLOIMMUNITY; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; GRAFT SURVIVAL; HEART TRANSPLANTATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; GENETICS; HETEROZYGOTE; POLYMERASE CHAIN REACTION; PREVALENCE; SURVIVOR;

FEMALE; GENOTYPE; GRAFT SURVIVAL; HEART TRANSPLANTATION; HETEROZYGOTE; HUMANS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREVALENCE; RECEPTORS, CCR5; SURVIVORS;

EID: 33847185960     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2006.11.004     Document Type: Article

References (26)

1. Pattison J., Nelson P.J., Huie P., et al. RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet 343 8891 (1994) 209-211
2. Robertson H., Wheeler J., Morley A.R., Booth T.A., Talbot D., and Kirby J.A. Beta-chemokine expression and distribution in paraffin-embedded transplant renal biopsy sections: analysis by scanning laser confocal microscopy. Histochem Cell Biol 110 2 (1998) 207-213
3. Gröne H.-J., Weber C., Weber K.S.C., et al. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEB J 13 11 (1999) 1371-1383
4. Ruster M., Sperschneider H., Funfstuck R., Stein G., and Grone H.J. Differential expression of beta-chemokines MCP-1 and RANTES and their receptors CCR1, CCR2, CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts. Clin Nephrol 61 1 (2004) 30-39
5. Yun J., Fischbein M.P., Laks H., et al. Early and late chemokine production correlates with cellular recruitment in cardiac allograft vasculopathy. Transplantation 69 12 (2000) 2515-2524
6. Mueller A., and Strange P.G. The chemokine receptor, CCR5. Int J Biochem Cell Biol 36 1 (2004) 35-38
7. Yi S., Ouyang L., Ha H., et al. Involvement of CCR5 signaling in macrophage recruitment to porcine islet xenografts. Transplantation 80 10 (2005) 1468-1475
8. Gao W., Faia K.L., Csizmadia V., et al. Beneficial effects of targeting CCR5 in allograft recipients. Transplantation 72 7 (2001) 1199-1205
9. Panzer U., Reinking R.R., Steinmetz O.M., et al. CXCR3 and CCR5 positive T-cell recruitment in acute human renal allograft rejection. Transplantation 78 9 (2004) 1341-1350
10. Nguyen B.N.H., Azimzadeh A.M., Zhang T., et al. CCR5 blockade prolongs survival and delays cardiac allograft vasculopathy (CAV) in non-human primates treated with cyclosporine A (CsA). J Heart Lung Transplant 25 2, Suppl (2006) 78-79
11. Fahmy N.M., Yamani M.H., Starling R.C., et al. Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants. Transplantation 75 1 (2003) 72-78
12. Horiguchi K., Kitagawa-Sakakida S., Sawa Y., et al. Selective chemokine and receptor gene expression in allografts that develop transplant vasculopathy. J Heart Lung Transplant 21 10 (2002) 1090-1100
13. Yun J.J., Whiting D., Fischbein M.P., et al. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection. Circulation 109 7 (2004) 932-937
14. Akashi S., Sho M., Kashizuka H., et al. A novel small-molecule compound targeting CCR5 and CXR3 prevents acute and chronic allograft rejection. Transplantation 80 3 (2005) 378-384
15. Samson M., Libert F., Doranz B.J., et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382 6593 (1996) 722-725
16. Fischereder M., Luckow B., Hocher B., et al. CC chemokine receptor 5 and renal-transplant survival. Lancet 357 9270 (2001) 1758-1761
17. Simeoni E., Vassalli G., Seydoux C., et al. CCR5, RANTES and CX3CR1 polymorphisms: possible genetic links with acute heart rejection. Transplantation 80 9 (2005) 1309-1315
18. Yigit B., Bozkurt N., Berber I., Titiz I., and Isbir T. Analysis of CC chemokine receptor 5 and 2 polymorphisms and renal transplant survival. Cell Biochem Funct (2006) [Electronic publication ahead of print]
19. Abdi R., Tran T.B., Sahagun-Ruiz A., et al. Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J Am Soc Nephrol 13 3 (2002) 754-758
20. Hoffman S., Park J., Jacobson L.M., et al. Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy. Kidney Int 66 4 (2004) 1686-1693
21. Schroppel B., Fischereder M., Ashkar R., et al. The impact of polymorphisms in chemokine and chemokine receptors on outcomes in liver transplantation. Am J Transplant 2 7 (2002) 640-645
22. Fildes J.E., Walker A.H., Howlett R., et al. Donor CCR5 Delta32 polymorphism and outcome following cardiac transplantation. Transplant Proc 37 5 (2005) 2247-2249
23. Stephens J.C., Reich D.E., Goldstein D.B., et al. Dating the origin of the CCR5-Delta32 AIDS-Resistance allele by the coalescence of haplotypes. Am J Hum Genet 62 6 (1998) 1507-1515
24. Luckow B., Joergensen J., Chilla S., et al. Reduced intragraft mRNA expression of matrix metalloproteinases Mmp3; Mmp12, Mmp13 and Adam8, and diminished transplant arteriosclerosis in Ccr5-deficient mice. Eur J Immunol 34 9 (2004) 2568-2578
25. Szalai C., Duba J., Proshaszka Z., et al. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1-2518 G/G genotype in CAD patients. Atherosclerosis 158 (2001) 233-239
26. Gonzalez P., Alvarez R., Batalla A., et al. Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction. Genes Immun 2 4 (2001) 191-195